| abstract |
This invention relates to novel compounds of the Formula I, II, III, IHa, NIb, IV, Na, IVb, IVc, IVd, IVe, V, Va, Vb1 V1, V1a, VIb, VII, VIIa, VIIb, VIII, VIIIa, VIIIb, IX, IXa, X, and Xa, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11 .beta.-HSD1 in mammals. The invention further relates to pharmaceutical compositions of the novel compounds and methods for their use in the reduction or control of the production of Cortisol in a cell or the inhibition of the conversion of cortisone to Cortisol in a cell. |